BCAR4 mRNA levels were measured in primary breast tumours, and evaluated for association with progression-free survival (PFS) and clinical benefit in patients with oestrogen receptor (ER&#945;)-positive tumours receiving tamoxifen as first-line monotherapy for advanced disease.
C1458155
Mammary Neoplasms